PedAM
Pediatric Disease Annotations & Medicines
| Disease | cholelithiasis |
| Phenotype | C0002895|sickle cell disease |
| Sentences | 3 |
| PubMedID- 24060717 | Background and objectives: polymorphism in (ta)n of the ugt1a1 promoter influences bilirubin level and risk of gallstones in patients with sickle cell disease (scd) of african descent. |
| PubMedID- 22888958 | It is the treatment of choice for gallstones in children with sickle cell disease [9]. |
| PubMedID- 24057785 | cholelithiasis in children with sickle cell disease. |
Page: 1